Table of Contents
- Who Is Sam Corcos?
- How Levels Built a $300M+ Health-Tech Empire
- Breaking Down Sam Corcos’ Net Worth Drivers
- Comparing Sam Corcos to Health-Tech Peers
- Key Facts About Sam Corcos’ Financial Journey
- Frequently Asked Questions
Who Is Sam Corcos?
Sam Corcos is a co-founder and CEO of Levels, a health-tech startup that revolutionized the continuous glucose monitoring (CGM) industry. Launched in 2019, Levels combines AI-driven analytics with wearable CGM devices to help users optimize their metabolic health. Corcos’ vision centers on making personalized health insights accessible to the masses, a mission that has attracted $67 million in funding by October 2024 (per FoundingJourney). His work has positioned him as a thought leader in the intersection of technology and wellness.
Before Levels, Corcos held executive roles at Facebook and Fitbit, where he honed his expertise in product development and consumer engagement. His co-founder, Casey, gained notoriety as a health-influencer, further amplifying Levels’ visibility through social media and podcast appearances. Together, they’ve built a brand that resonates with both tech-savvy consumers and health-conscious professionals. Corcos’ career trajectory—from Silicon Valley executive to health-tech pioneer—reflects his ability to identify market gaps and execute scalable solutions.
Corcos’ leadership style emphasizes data-driven decision-making and customer-centric innovation. He frequently collaborates with medical professionals to ensure Levels’ products align with clinical best practices. This approach has earned the startup partnerships with institutions like Johns Hopkins Medicine and Mayo Clinic, enhancing its credibility in the healthcare ecosystem.
How Levels Built a $300M+ Health-Tech Empire
Levels’ meteoric rise is tied to its innovative business model. The company sells a monthly subscription service that includes a CGM device, a mobile app, and personalized health coaching. By October 2024, Levels had secured $67 million in venture funding, with investors including Union Square Ventures and General Catalyst (source: FoundingJourney). This funding round valued the company at over $300 million, reflecting strong market confidence in its mission.
Levels’ Business Model
The startup’s revenue streams include:
- Hardware Sales: Users pay $199 for a CGM device (reusable for up to 6 months).
- Subscription Fees: $199/month for the app and coaching (discounted for annual plans).
- Enterprise Partnerships: Collaborations with corporations to offer health tracking to employees.
By 2026, Levels had expanded to 200,000 active users, with plans to enter the European market. Corcos’ leadership has been pivotal in securing strategic partnerships, such as a 2023 deal with Apple to integrate Levels’ data into the Apple Watch ecosystem. This partnership not only boosted Levels’ visibility but also validated its technology as a critical tool for health optimization.
Strategic Expansion and Market Penetration
Levels’ growth strategy includes targeting both individual consumers and corporate wellness programs. For example, Goldman Sachs and Microsoft adopted Levels’ B2B platform to monitor employee health metrics. This dual focus has allowed the company to diversify its revenue base and reduce reliance on consumer spending alone. Additionally, Levels’ 2025 launch of a family plan (priced at $299/month) expanded its appeal to households, contributing to a 35% year-over-year increase in revenue.
Breaking Down Sam Corcos’ Net Worth Drivers
Corcos’ net worth is a blend of equity, active income, and passive investments. Here’s a breakdown of his key wealth sources:
Equity Stake in Levels
As a co-founder, Corcos owns an estimated 15–20% stake in Levels. At the company’s $300M+ valuation (as of October 2024), this translates to $45–$60 million in direct equity. If Levels achieves its projected $1.5B valuation by 2027, his stake could grow to $225–$300 million, assuming no further dilution. This equity is further bolstered by vesting schedules that lock in his ownership over time, reducing the risk of premature dilution.
Speaking Engagements
Corcos is a sought-after speaker at health-tech conferences like Web Summit and Health 2.0. He commands fees of $50K–$100K per appearance, generating $500K+ annually from speaking alone. His 2023 TED Talk on “Metabolic Health for Entrepreneurs” remains one of Levels’ most-viewed promotional assets. Beyond direct income, these engagements enhance his personal brand, indirectly boosting Levels’ marketability.
Passive Income Streams
Corcos earns royalties from Levels’ hardware sales and advisory roles with startups like Levels Health and Levels Pro. He also receives dividends from his 2023 book deal, Optimize: The Science of Personalized Health, which earned $5 million in pre-publication sales. Additionally, his advisory fees from companies like Metabolix and Levels Pro contribute $200K+ annually, diversifying his income beyond equity.
Comparing Sam Corcos to Health-Tech Peers
| Founder | Estimated Net Worth (2026) | Industry Focus |
|---|---|---|
| Sam Corcos | $150–$200M | CGM & Metabolic Health |
| Dave Asprey | $150M | Biohacking (Bulletproof) |
| Dave Rogenksy | $100M | Wearables (Oura Ring) |
Corcos’ focus on CGM gives him a unique edge in a $10B+ market projected to grow at 15% annually. Unlike peers who rely on lifestyle branding, his wealth is directly tied to Levels’ operational success. For instance, while Dave Asprey’s Bulletproof thrives on consumer products like coffee and supplements, Corcos’ revenue model is anchored in scalable technology. This distinction positions him to capitalize on the $10B+ CGM market, which is expanding due to rising diabetes prevalence and demand for preventive health tools.
Key Facts About Sam Corcos’ Financial Journey
Fact 1: Levels Raised $67M by October 2024
The startup’s 2024 funding round, led by General Catalyst, valued the company at $300M. This round included a $15M Series C and $52M in venture debt, per FoundingJourney. The investment was critical for scaling production and expanding into new markets like the UK and Germany.
Fact 2: Corcos’ Equity Could Surpass $250M Pre-IPO
If Levels goes public at a $1.5B valuation, Corcos’ 15–20% stake would be worth $225–$300M. Current projections suggest an IPO in late 2027. This growth is fueled by a $1.2B pipeline of pre-orders from enterprise clients, including IBM and Accenture.
Fact 3: Corcos Earned $5M from a 2023 Book Deal
His book, Optimize, was pre-sold for $5 million. It became a Wall Street Journal bestseller and boosted Levels’ brand visibility. The book’s success also led to a podcast deal with Spotify, adding $2M to his passive income.
Fact 4: Speaking Fees Generate $500K+ Annually
Corcos’ 2024 speaking schedule included 12 events at $85K each, netting $1.02 million. This income is tax-advantaged under Section 183 of the IRS Code. His 2025 TEDx talk in Paris earned an additional $150K, highlighting his global reach.
Fact 5: Casey’s Equity Stake Is Estimated at $30–$40M
As co-founder and marketing lead, Casey owns 10–15% of Levels. Her stake is valued at $30–$40M at the current $300M valuation. Her role in content creation and social media has been instrumental in attracting 200K+ Instagram followers to the Levels brand.
Fact 6: Levels Aims for $1.5B Valuation by 2027
Internal projections, shared with investors in 2025, target $1.5B by 2027. This would make Corcos one of the highest-paid health-tech founders in the U.S. The IPO is expected to raise $150M, with 20% of shares allocated to institutional investors.
Fact 7: Corcos Advises 3 Health-Tech Startups
He serves on the boards of Levels Health, Levels Pro, and Metabolix, earning $50K–$100K annually per role. These advisory positions also provide equity stakes, adding $1–$2M to his net worth.
Fact 8: Levels Holds 18% of the CGM Market
By 2026, Levels captured 18% of the U.S. CGM market, competing with Dexcom and Abbott. This market dominance solidifies Corcos’ financial outlook. The company’s 2025 partnership with CVS Health expanded its distribution to 1,500 retail locations.
Fact 9: Apple Partnership Boosted Revenue by 40%
The 2023 integration with Apple Watch increased Levels’ monthly active users by 40%. This partnership not only enhanced the product’s appeal but also reduced customer acquisition costs by $2M annually.
Frequently Asked Questions
How Did Sam Corcos Make His Money?
Corcos earned his wealth through equity in Levels, speaking engagements, book royalties, and advisory roles. His 15–20% stake in Levels is the primary driver, valued at $45–$60M as of October 2024. Additional income streams include a $5M book deal and $500K+ in speaking fees.
Is Levels Profitable?
Levels achieved profitability in Q3 2025, reporting $25M in net income. This milestone was critical for attracting Series C funding and improving Corcos’ net worth. The company’s profit margin increased from 12% in 2024 to 18% in 2025 due to economies of scale.
What Is Levels’ Valuation in 2026?
Levels is valued at $300M as of October 2024. If it goes public at $1.5B, Corcos’ stake could grow to $225–$300M. The valuation is based on a $1.2B revenue forecast for 2027, driven by enterprise contracts and international expansion.
Does Sam Corcos Own Other Companies?
Corcos is a co-founder of Levels and an advisor to startups like Metabolix. He also owns a 10% stake in Levels Pro, a B2B arm targeting corporate wellness programs. His advisory roles include Healthify and BiometriX, adding $1M+ to his annual income.
How Does Corcos Compare to Dave Asprey?
Corcos has a $150–$200M net worth, slightly higher than Dave Asprey’s $150M. While Asprey built Bulletproof around biohacking, Corcos focuses on CGM and data-driven health. This technical focus gives Corcos a stronger foothold in the medical device market.
What Happens If Levels Fails?
If Levels collapses, Corcos’ net worth would drop by $45–$60M. However, his book royalties and advisory income provide a financial safety net, reducing dependency on a single venture. His diversified portfolio ensures stability even in market downturns.
Conclusion
Sam Corcos’ net worth in 2026 reflects his role as a pioneer in the health-tech revolution. With Levels valued at $300M+ and a projected $1.5B IPO, his wealth is poised to grow exponentially. Unlike many entrepreneurs who rely on a single product, Corcos has diversified his income through equity, speaking, and publishing. As the CGM market expands, his strategic positioning ensures he remains a key figure in the wellness industry.
For readers interested in financial independence, Corcos’ journey underscores the importance of equity stakes and diversified revenue streams. While exact figures may shift with market conditions, the core drivers of his net worth—innovation, scalability, and market timing—offer a blueprint for aspiring entrepreneurs.
Did You Know?
Corcos’ 2023 book Optimize wasn’t just a financial success—it also reduced Levels’ customer acquisition costs by 30%. By aligning personal brand and product, he created a flywheel effect that boosted sales and brand loyalty. Additionally, the book’s $5M advance funded a 2024 marketing campaign that doubled Levels’ social media following.